Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    February 2017
  1. SEPULVEDA AR, Hamilton SR, Allegra CJ, Grody W, et al
    Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017 Feb 6:JCO2016719807. doi: 10.1200/JCO.2016.71.9807.
    PubMed     Text format     Abstract available


    January 2017
  2. YURGELUN MB, Kulke MH, Fuchs CS, Allen BA, et al
    Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    J Clin Oncol. 2017 Jan 30:JCO2016710012. doi: 10.1200/JCO.2016.71.0012.
    PubMed     Text format     Abstract available


  3. CASADABAN L, Maker AV
    Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature?
    J Clin Oncol. 2017 Jan 23:JCO2016711572. doi: 10.1200/JCO.2016.71.1572.
    PubMed     Text format    


    December 2016
  4. NAGTEGAAL ID, Knijn N, Hugen N, Marshall HC, et al
    Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2016 Dec 28:JCO2016689091.
    PubMed     Text format     Abstract available


  5. LOEHRER AP, Song Z, Haynes AB, Chang DC, et al
    Impact of Health Insurance Expansion on the Treatment of Colorectal Cancer.
    J Clin Oncol. 2016;34:4110-4115.
    PubMed     Text format     Abstract available


    September 2016
  6. CESPEDES FELICIANO EM, Kroenke CH, Meyerhardt JA, Prado CM, et al
    Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.
    J Clin Oncol. 2016 Sep 6. pii: JCO674473.
    PubMed     Text format     Abstract available


    August 2016
  7. SARGENT DJ, Andre T, Grothey A
    Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer.
    J Clin Oncol. 2016 Aug 15. pii: JCO684886.
    PubMed     Text format    


  8. DALY LE, Ryan AM, Power DG
    Response to "Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer".
    J Clin Oncol. 2016 Aug 1. pii: JCO688010.
    PubMed     Text format    


    July 2016
  9. NIEDZWIECKI D, Frankel WL, Venook AP, Ye X, et al
    Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
    J Clin Oncol. 2016 Jul 18. pii: JCO654699.
    PubMed     Text format     Abstract available


    June 2016
  10. YAMANAKA T, Oki E, Yamazaki K, Yamaguchi K, et al
    12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.
    J Clin Oncol. 2016 Jun 20. pii: JCO670414.
    PubMed     Text format     Abstract available


    May 2016
  11. BAINS SJ, Mahic M, Myklebust TA, Smastuen MC, et al
    Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.
    J Clin Oncol. 2016 May 31. pii: JCO653519.
    PubMed     Text format     Abstract available


  12. HOLOWATYJ AN, Ruterbusch JJ, Rozek LS, Cote ML, et al
    Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer.
    J Clin Oncol. 2016 May 2. pii: JCO650994.
    PubMed     Text format     Abstract available


  13. HUANG YQ, Liang CH, He L, Tian J, et al
    Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.
    J Clin Oncol. 2016 May 2. pii: JCO659128.
    PubMed     Text format     Abstract available


    April 2016
  14. SEGELOV E, Thavaneswaran S, Waring PM, Desai J, et al
    Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.
    J Clin Oncol. 2016 Apr 25. pii: JCO656843.
    PubMed     Text format     Abstract available


  15. RICCI R, Martini M, Cenci T, Antinori A, et al
    Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive.
    J Clin Oncol. 2016;34:e107-9.
    PubMed     Text format    


  16. HOCHSTER HS, Niedzwiecki D
    Big Data, Small Effects.
    J Clin Oncol. 2016;34:1170-1.
    PubMed     Text format    


  17. GASPAROTTO D, Rossi S, Campagna D, Scavina P, et al
    Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.
    J Clin Oncol. 2016;34:e99-e103.
    PubMed     Text format    


    March 2016
  18. NASTI G, Ottaiano A
    Best Sequence Therapy in RAS Wild-Type Metastatic Colorectal Cancer: Waiting for Randomized Crossover Clinical Trials.
    J Clin Oncol. 2016 Mar 7. pii: JCO659086.
    PubMed     Text format    


  19. VENTURINI F, Gambi V, Di Lernia S, Vanzulli A, et al
    Linitis Plastica of the Rectum As a Clinical Presentation of Metastatic Lobular Carcinoma of the Breast.
    J Clin Oncol. 2016;34:e54-6.
    PubMed     Text format    


    February 2016
  20. SALTZ LB
    Genetic Screening in All Young Patients With Colorectal Cancer?
    J Clin Oncol. 2016 Feb 29. pii: JCO659847.
    PubMed     Text format    


  21. LATHAN CS, Cronin A, Tucker-Seeley R, Zafar SY, et al
    Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer.
    J Clin Oncol. 2016 Feb 29. pii: JCO632232.
    PubMed     Text format     Abstract available


  22. VAN HAZEL GA, Heinemann V, Sharma NK, Findlay MP, et al
    SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2016 Feb 22. pii: JCO661181.
    PubMed     Text format     Abstract available


  23. BLAUWHOFF-BUSKERMOLEN S, Versteeg KS, de van der Schueren MA, den Braver NR, et al
    Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2016 Feb 22. pii: JCO636043.
    PubMed     Text format     Abstract available


  24. PAHLMAN LA, Hohenberger WM, Matzel K, Sugihara K, et al
    Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?
    J Clin Oncol. 2016 Feb 22. pii: JCO653048.
    PubMed     Text format    


  25. CHEUNG WY, Renfro LA, Kerr D, de Gramont A, et al
    Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.
    J Clin Oncol. 2016 Feb 8. pii: JCO651158.
    PubMed     Text format     Abstract available


    January 2016
  26. SHAH MA, Renfro LA, Allegra CJ, Andre T, et al
    Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
    J Clin Oncol. 2016 Jan 25. pii: JCO630558.
    PubMed     Text format     Abstract available


  27. DEENEN MJ, Meulendijks D, Cats A, Sechterberger MK, et al
    Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.
    J Clin Oncol. 2016;34:227-34.
    PubMed     Text format     Abstract available


  28. HEGARTY S, Shapiro PJ, Fang CY, Barsevick AM, et al
    Physical and mental functioning in colorectal cancer (CRC) survivors by work status.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  29. SMITH V, Danus S, Schnell M, Lindquist J, et al
    Colorectal cancer survivorship statistics: A Veterans Affairs Central Cancer Registry analysis.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  30. VAN LOON K, You YN, Hu CY, Francescatti AB, et al
    How clinicians make decisions regarding surveillance and treatment of colorectal cancer (CRC) patients.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  31. GOUGH K, Drosdowsky A, Russell L, Aranda S, et al
    A randomized controlled trial (RCT) of a supportive care package (SurvivorCare, SC) for survivors of colorectal cancer (CRC).
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


  32. ALLEGRA CJ, Rumble RB, Hamilton SR, Mangu PB, et al
    Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.
    J Clin Oncol. 2016;34:179-85.
    PubMed     Text format     Abstract available


    December 2015
  33. AN MW, Han Y, Meyers JP, Bogaerts J, et al
    Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.
    J Clin Oncol. 2015;33:4048-57.
    PubMed     Text format     Abstract available


    November 2015
  34. FASOLA G, Aprile G, Pinto C
    Balancing Clinical Progress With Economic Sustainability: In Quest of a Courageous Solution.
    J Clin Oncol. 2015;33:3841-2.
    PubMed     Text format    


  35. SALTZ LB
    Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al.
    J Clin Oncol. 2015;33:3843-4.
    PubMed     Text format    


  36. BORDONARO R, Cordio S, Uccello M, Martines C, et al
    Bevacizumab Plus Chemotherapy Cost Effectiveness.
    J Clin Oncol. 2015;33:3840-1.
    PubMed     Text format    


  37. GOLDSTEIN DA, El-Rayes BF, Chen Q, Flowers CR, et al
    Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al.
    J Clin Oncol. 2015;33:3842-3.
    PubMed     Text format    


  38. O'NEIL BH, Venook AP
    Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others?
    J Clin Oncol. 2015;33:3686-8.
    PubMed     Text format    


  39. HENNINK SD, van der Meulen-de Jong AE, Wolterbeek R, Crobach AS, et al
    Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer.
    J Clin Oncol. 2015 Nov 2. pii: JCO.2015.62.2035.
    PubMed     Text format     Abstract available


  40. VARDY JL, Dhillon HM, Pond GR, Rourke SB, et al
    Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
    J Clin Oncol. 2015 Nov 2. pii: JCO.2015.63.0905.
    PubMed     Text format     Abstract available


  41. ANDRE T, de Gramont A, Vernerey D, Chibaudel B, et al
    Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
    J Clin Oncol. 2015 Nov 2. pii: JCO.2015.63.4238.
    PubMed     Text format     Abstract available


  42. MURPHY DR, Wu L, Thomas EJ, Forjuoh SN, et al
    Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for Cancer: A Cluster Randomized Controlled Trial.
    J Clin Oncol. 2015;33:3560-7.
    PubMed     Text format     Abstract available


  43. FLEMING GF
    Second-Line Therapy for Endometrial Cancer: The Need for Better Options.
    J Clin Oncol. 2015;33:3535-40.
    PubMed     Text format    


    October 2015
  44. VAN CUTSEM E, Beier F, Ciardiello F
    Reply to S. Debska-Szmich et al.
    J Clin Oncol. 2015;33:3518.
    PubMed     Text format    


  45. KANTER MH, Schottinger JE, Copeland R
    Integration Alone Does Not Reduce Health Care Disparities.
    J Clin Oncol. 2015;33:3519.
    PubMed     Text format    


  46. RHOADS KF, Patel MI, Ma Y, Schmidt LA, et al
    Reply to M.H. Kanter et al.
    J Clin Oncol. 2015;33:3519.
    PubMed     Text format    


  47. PACHMAN DR, Qin R, Seisler DK, Smith EM, et al
    Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).
    J Clin Oncol. 2015;33:3416-22.
    PubMed     Text format     Abstract available


  48. LIN CC, Bruinooge SS, Kirkwood MK, Olsen C, et al
    Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
    J Clin Oncol. 2015;33:3177-85.
    PubMed     Text format     Abstract available


    August 2015
  49. DE VRIES EG, de Jong S, Gietema JA
    Molecular Imaging As a Tool for Drug Development and Trial Design.
    J Clin Oncol. 2015;33:2585-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: